NTCA Provider Guidance on Using the Isoniazid/Rifapentine Regimen to Treat Latent Tuberculosis Infection (LTBI)2018 National TB Conference Cyber Poster Session

About the National Tuberculosis Controllers Association

The NTCA was created in 1995 to bring together the leaders of tuberculosis control programs in all states and territories, as well as many counties and city health departments that organize their own TB control activities. Learn more…

  • Home page noteworthy


    Updated Recommendations Released for Health Care Personnel

    May 16 — NTCA, in partnership with the CDC, is pleased to announce the release of updated recommendations for TB screening, testing, and treatment of health care personnel. Central to the new recommendations is stopping routine, annual testing of all health care personnel and the emphasis on LTBI treatment, an essential component of national efforts to eliminate TB. We extend our thanks to Lynn Sosa and Bob Belknap, who led the national workgroup, and to the committed stakeholders from NTCA and our partner organizations who gave their time and effort to this project. For more details, see the NTCA press release and the updated recommendations.

    New Activist Guide on Rifapentine for Preventing TB

    May 10 — The Treatment Action Group (TAG) has released An Activist’s Guide to Rifapentine, which details important efficacy, safety, and access information on rifapentine, a game-changing drug for treating tuberculosis (TB) infection in order to prevent active TB disease.

    2019 Elections: Call for Nominations

    May 7 — Nominate yourself or a colleague to serve on the NTCA Board.